CIPO Patents = 1

EPO Patents = 3

Forward Citations = 44

Loading Chart...

3 inventors (with patents filed for the assignee):

Jonathan Edelson (6 out of 11 patents)

Timothy Kotyla (6 out of 6 patents)

Boke Zhang (1 out of 5 patents)

4. Klaus Theobald (1 patent)

9 patents: Sort by Forward Citations

1. 10905637 - Peptide nanoparticles and uses therefor (2021-02-02),

2. 10758485 - Amphiphilic entity nanoparticles (2020-09-01),

3. 10485855 - Demonstrable efficacy across or within patient populations (2019-11-26),

4. 10285941 - Amphiphilic entity nanoparticles (2019-05-14),

5. 10016451 - Nucleic acid nanoparticles and uses therefor (2018-07-10),

6. 9724299 - Amphiphilic entity nanoparticles (2017-08-08),

7. 9649266 - Methods to treat, prevent, and improve skin conditions (2017-05-16),

8. 9486409 - Peptide nanoparticles and uses therefor (2016-11-08),

9. 8658391 - Assessment of the effects of topical administration of chemodenervating pharmaceuticals (2014-02-25),

Anterios, Inc. is a biopharmaceutical company focused on developing novel aesthetic treatments utilizing their proprietary transdermal delivery technology. Their lead product, NANOG, is a botulinum toxin type A product that penetrates the skin more effectively, providing better results with less discomfort for patients. Anterios is dedicated to advancing the field of dermatology and improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

9 Patents

#695 in New York, NY

#1,797 in New York

#31,616 in US

New York, NY, United States of America

Anterios, Inc.

Forward Citations = 44

3 inventors:

Jonathan Edelson (6 out of 11 patents)

Timothy Kotyla (6 out of 6 patents)

Boke Zhang (1 out of 5 patents)

4. Klaus Theobald (1 patent)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com